Geoffrey Ling M.D.
CIK 1800097 · View on SEC EDGAR ↗
Insider
First SEC filing: Oct. 16, 2023 · Latest: Oct. 16, 2023
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 12 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
12 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 25, 2020 | GYRE | P | 3,000 | $6.23 | $18,690 | 3,000 Direct | — | Acquired | -92.5% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 31, 2023 | CELU | Stock Option Grant (Right to Buy) | Class A Common Stock (1,250,000) | $0.32 | Aug. 31, 2033 | 1,250,000 | Acquired |
| June 9, 2021 | GYRE | Stock Option (Right to Buy) | Common Stock (14,000) | $4.55 | June 9, 2031 | 14,000 | Acquired |
| June 11, 2020 | GYRE | Stock Option (Right to Buy) | Common Stock (5,000) | $7.18 | June 11, 2030 | 5,000 | Acquired |
| Jan. 15, 2020 | GYRE | Stock Option (Right to Buy) | Common Stock (10,000) | $7.29 | Jan. 15, 2030 | 10,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).